A 58-year-old female smoker with end-stage chronic obstructive pulmonary disease and osteoarthritis is on ipratropium bromide and albuterol inhalers, and hydrocodone-acetaminophen. She presents with respiratory distress for 2 days accompanied by increased thick, yellow sputum production, low grade fever, and increasing confusion. On examination she is mildly obtunded but arousable, BP 160/100, pulse 115/min, RR 30/min, O2 saturation 84% on her usual 3 L/min nasal cannula oxygen. She is using accessory muscles to breath, has diffuse wheezing and rhonchi bilaterally, a prolonged expiratory phase, distant but regular heart sounds, and no peripheral edema.Arterial blood gases (ABGs) on arrival are as follows:pH: 7.20,PO2: 70 mm HgPCO2: 65 mm Hgcalculated HCO3 29 mEq/L.Electrolytes return shortly thereafter as follows:Na: 140 mEq/LK: 5.1 mEq/LHCO3: 29 mEq/LCl: 100 mEq/LBUN 20 mg/dL creatinine 1.5 mg/dLglucose 89 mg/dL.After prompt initiation of noninvasive positive pressure ventilation (Bi-pap), blood cultures, toxicology screen, intravenous fluids, and IV antibiotics, you have time to consider the patient’s metabolic situation. Choose the answer which best describes the acid-base condition and its etiology.
A 58-year-old female smoker with end-stage chronic obstructive pulmonary disease and osteoarthritis is on ipratropium bromide and albuterol inhalers, and hydrocodone-acetaminophen. She presents with respiratory distress for 2 days accompanied by increased thick, yellow sputum production, low grade fever, and increasing confusion. On examination she is mildly obtunded but arousable, BP 160/100, pulse 115/min, RR 30/min, O2 saturation 84% on her usual 3 L/min nasal cannula oxygen. She is using accessory muscles to breath, has diffuse wheezing and rhonchi bilaterally, a prolonged expiratory phase, distant but regular heart sounds, and no peripheral edema.Arterial blood gases (ABGs) on arrival are as follows:pH: 7.20,PO2: 70 mm HgPCO2: 65 mm Hgcalculated HCO3 29 mEq/L.Electrolytes return shortly thereafter as follows:Na: 140 mEq/LK: 5.1 mEq/LHCO3: 29 mEq/LCl: 100 mEq/LBUN 20 mg/dL creatinine 1.5 mg/dLglucose 89 mg/dL.After prompt initiation of noninvasive positive pressure ventilation (Bi-pap), blood cultures, toxicology screen, intravenous fluids, and IV antibiotics, you have time to consider the patient’s metabolic situation. Choose the answer which best describes the acid-base condition and its etiology.
💡 Explanation
**Core Concept**
The patient's presentation with respiratory distress, increased sputum production, and ABGs showing a low pH, elevated PCO2, and elevated HCO3 levels indicates a complex acid-base disorder. This scenario involves a mixed acid-base disturbance, specifically a respiratory acidosis with a metabolic alkalosis.
**Why the Correct Answer is Right**
The patient's elevated PCO2 (65 mm Hg) and decreased pH (7.20) indicate a primary respiratory acidosis. The elevated HCO3 level (29 mEq/L) is a compensatory response to the respiratory acidosis, attempting to buffer the excess hydrogen ions. However, the presence of a metabolic alkalosis is also evident, as suggested by the elevated HCO3 level and the absence of a significant anion gap. This is likely due to the patient's vomiting or nasogastric suction, leading to the loss of hydrogen ions and chloride, resulting in a metabolic alkalosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it suggests a simple metabolic acidosis, which is not supported by the elevated HCO3 level and the absence of a significant anion gap.
**Option B:** This option is incorrect as it suggests a simple respiratory acidosis with a normal HCO3 level, which does not account for the elevated HCO3 level in this patient.
**Option C:** This option is incorrect as it suggests a mixed disorder with a significant anion gap, which is not supported by the electrolyte panel showing a normal anion gap (Na - (Cl + HCO3) = 0).
**Option D:** This option is incorrect as it suggests a simple metabolic alkalosis with a normal PCO2, which does not account for the elevated PCO2 and the primary respiratory acidosis.
**Clinical Pearl / High-Yield Fact**
In patients with respiratory acidosis, the primary treatment is addressing the underlying cause, such as noninvasive positive pressure ventilation (Bi-pap) in this case. However, it's essential to also consider the presence of a metabolic alkalosis, which may require additional treatment, such as IV fluids and possibly IV acetazolamide.
**Correct Answer:** C.
✓ Correct Answer: D. The patient has a baseline chronic respiratory acidosis with metabolic compensation, now with a superimposed further respiratory acidosis caused by decreased ventilation.
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram